May 19, 2026 08:01AM
May 14, 2026 07:30AM
Mar 19, 2026 09:25AM
Mar 9, 2026 09:15AM
Mar 9, 2026 09:15AM
Feb 17, 2026 09:15AM
Feb 17, 2026 09:15AM Biofrontera Inc. Announces Database Lock of Phase 1 Pharmacokinetics Study of Ameluz® for Actinic Keratoses on Trunk and Extremities
Feb 11, 2026 09:16AM
Feb 11, 2026 09:15AM
Feb 9, 2026 09:15AM
Feb 9, 2026 09:15AM
Jan 8, 2026 08:46AM
Jan 8, 2026 08:45AM
Dec 18, 2025 08:45AM Biofrontera completes transfer of Ameluz and RhodoLED FDA approvals
Dec 18, 2025 08:45AM
Dec 4, 2025 09:00AM
Dec 4, 2025 09:00AM
Dec 2, 2025 08:45AM
Dec 2, 2025 08:45AM
Nov 13, 2025 08:15AM
Nov 7, 2025 08:00AM Biofrontera sells Xepi antibiotic license to Pelthos for up to $10 million
Nov 7, 2025 08:00AM
Sep 16, 2025 10:30AM
Sep 16, 2025 10:30AM
Sep 16, 2025 10:30AM
Aug 25, 2025 08:27AM
Aug 25, 2025 08:25AM
Aug 11, 2025 04:25PM Biofrontera names George Jones as chief commercial officer
Aug 11, 2025 04:25PM
Jun 30, 2025 08:00AM
Jun 3, 2025 02:30PM
Jun 3, 2025 02:30PM
May 15, 2025 12:17PM
May 15, 2025 12:17PM
Mar 21, 2025 08:00AM Biofrontera Inc. Reports Record Fiscal Year 2024 Financial Results and Provides a Business Update
Mar 18, 2025 09:30AM
Jan 8, 2025 09:51AM
Jan 8, 2025 09:50AM
Dec 23, 2024 09:31AM
Dec 23, 2024 09:30AM
Nov 13, 2024 05:15PM
Oct 31, 2024 10:33AM Biofrontera Inc. (BFRI) Announces Highly Significant Results In Phase 3 Study Of Ameluz®-Photodynamic Therapy (PDT) Regarding The Treatment Of Superficial Basal Cell Carcinoma
Oct 31, 2024 10:32AM
Oct 14, 2024 10:30AM
Oct 14, 2024 10:30AM
Oct 7, 2024 02:04PM
Oct 7, 2024 08:45AM
Oct 7, 2024 08:45AM
Aug 14, 2024 04:30PM Biofrontera Inc. Reports Second Quarter 2024 Financial Results and Provides a Business Update
Jun 24, 2024 11:55AM

323,571 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All